InBrain Neuroelectronics wins FDA breakthrough nod for intelligent network modulation system

InBrain Neuroelectronics announced today that it received FDA breakthrough device designation for its intelligent network modulation system. The breakthrough nod covers the graphene-neural platform as an adjunctive therapy for treating Parkinson’s disease. InBrain’s system harnesses the power of graphene, a two-dimensional material made of a lattice of carbon atoms. The thin material — stronger than … Continue reading InBrain Neuroelectronics wins FDA breakthrough nod for intelligent network modulation system